Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ilepatril

Known as: (4S,7S,12BR)-7-((2S)-2-(Acetylsulfanyl)-3-Methylbutanamido)-6-Oxo-1,2,3,4,6,7,8,12b-Octahydropyrido(2,1-A)(2)Benzazepine-4-Carboxylic Acid 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
OBJECTIVE The aim of the present study was to compare the preventive impact of treatment with a vasopeptidase inhibitor (VPI… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2012
2012
PURPOSE Cornea confocal microscopy is emerging as a clinical tool to evaluate the development and progression of diabetic… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2012
2012
Treating high fat fed/low dose streptozotocin-diabetic rats; model of type 2 diabetes, with ilepatril (vasopeptidase inhibitor… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2012
2012
We have demonstrated that treating diet-induced obese (DIO) mice with the vasopeptidase inhibitor ilepatril improved neural… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
2012
2012
  • Nathan Efron
  • Investigative ophthalmology & visual science
  • 2012
  • Corpus ID: 11779516
N europathy is a frequent complication of diabetes and is a major cause of morbidity and mortality, potentially affecting distal… Expand
Is this relevant?
2011
2011
We have previously shown that treating streptozotocin-induced diabetic rats, an animal model of type 1 diabetes, with Ilepatril… Expand
Is this relevant?
2011
2011
Previously we demonstrated that inhibition of neutral endopeptidase (NEP), a protease that degrades vaso- and neuro-active… Expand
Is this relevant?
2011
2011
We have previously shown that treating streptozotocin-induced diabetic rats, an animal model of type 1 diabetes, with Ilepatril… Expand
Is this relevant?
Review
2008
Review
2008
  • Reza Tabrizchi
  • Current opinion in investigational drugs
  • 2008
  • Corpus ID: 11705565
sanofi-aventis (formerly Aventis Pharma AG) is developing ilepatril (AVE-7688), a dual angiotensin-converting enzyme and neutral… Expand
Is this relevant?